The Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center is seeking applications for its Central Nervous System and Stereotactic Radiosurgery Fellowship. This non-ACGME accredited advanced radiation oncology training fellowship program is a 2-year combined clinical and translational research program.
This exciting opportunity includes intensive clinical and research training focusing on the management and study of primary and secondary CNS malignancies. Trainees will receive comprehensive clinical training in all critical modalities for the management of CNS tumors, including VMAT/IMRT, proton radiotherapy, stereotactic radiosurgery, and intracranial brachytherapy.
MSK treats more than 2,000 new patients per year with CNS malignancies, and thus, the trainee can expect to receive broad exposure to the management of both common and rare primary and secondary CNS malignancies.
The program includes a minimum of 30% dedicated time for research activities, which is expected to be spent pursuing high-impact translational research in CNS tumors, making use of extensive departmental and institutional resources, including a vast set of Core facilities and incredibly talented collaborators in biostatistics. Trainees will make use of modern techniques in genomic sequencing, including single-cell and spatial techniques, as well as machine-learning methods.
The duration of the fellowship is two years. During the fellowship year, the fellow will develop both practical and hands-on technical experience in performing a variety of radiation techniques and clinical expertise in the clinical management of brain tumors. Fellows will have the opportunity to interact and collaborate with our multidisciplinary experts in medical oncology, neuro-oncology, and neurosurgery. Formal practical and didactic training is also an integral part of the experience provided. After successful completion of the fellowship, the fellow will have the tools to function as an independent consultant with clinical and technical expertise in the management of primary and secondary CNS malignancies.
Under directed mentorship, the fellow will be able to devote 30% of his/her time to research. Fellows will meet regularly with mentors to oversee progress, which will ultimately culminate in presentation at society meeting(s) and peer-reviewed publication(s). Structured training opportunities will be provided in study development, research conduct, and grant writing. Financial support will be provided for travel to conferences.
Length of Program
Two years
Eligibility
The fellowship applicant must meet the following requirements:
- Completion of a radiation oncology residency
- Be eligible for a New York Medical License and able to obtain one by the start date (tentatively July 1, 2024, but negotiable)
- If not a US citizen or green card holder, be eligible for an H1B visa (requires completion of USMLE Steps 1, 2, and 3)
- ABR certification/eligibility in Radiation Oncology or an equivalent board. Canadian graduates are expected to have passed their qualifying exams from the Royal College.
- NYS Controlled Substance Registration
Application
Please the link below to apply for a fellowship position.